CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
1.8958
3.56%
Market Trading Hours* (UTC) Opens on Monday at 13:30

Mon - Fri: 13:30 - 20:00

  • Summary
  • Historical Data
Trading сonditions
Spread 0.0184
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026179 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026179%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003957 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003957%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 1.9658
Open 1.9858
1-Year Change 196.39%
Day's Range 1.8658 - 1.9858
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
May 17, 2024 1.8958 -0.0700 -3.56% 1.9658 2.0058 1.8558
May 16, 2024 1.9658 0.0600 3.15% 1.9058 2.0458 1.8958
May 15, 2024 1.9458 0.2000 11.46% 1.7458 1.9858 1.6858
May 14, 2024 1.6958 0.0400 2.42% 1.6558 1.8058 1.6358
May 13, 2024 1.7958 0.1700 10.46% 1.6258 1.8158 1.6258
May 10, 2024 1.5858 -0.0800 -4.80% 1.6658 1.6758 1.5358
May 9, 2024 1.6599 -0.0300 -1.78% 1.6899 1.7099 1.6099
May 8, 2024 1.7099 0.1800 11.77% 1.5299 1.7399 1.5099
May 7, 2024 1.5599 -0.0500 -3.11% 1.6099 1.6999 1.5099
May 6, 2024 1.6299 0.2900 21.64% 1.3399 1.6399 1.3399
May 3, 2024 1.3199 -0.0500 -3.65% 1.3699 1.4099 1.3199
May 2, 2024 1.3299 -0.0600 -4.32% 1.3899 1.3999 1.3199
May 1, 2024 1.3799 0.0700 5.34% 1.3099 1.4299 1.3099
Apr 30, 2024 1.3099 -0.0600 -4.38% 1.3699 1.3799 1.2499
Apr 29, 2024 1.3799 0.1200 9.52% 1.2599 1.4299 1.2599
Apr 26, 2024 1.2699 0.0700 5.83% 1.1999 1.2999 1.1899
Apr 25, 2024 1.1699 0.0200 1.74% 1.1499 1.2399 1.1099
Apr 24, 2024 1.1699 -0.1100 -8.59% 1.2799 1.2799 1.1499
Apr 23, 2024 1.2299 0.0200 1.65% 1.2099 1.2999 1.1699
Apr 22, 2024 1.2299 -0.1200 -8.89% 1.3499 1.3499 1.1999

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Ocugen, Inc. Company profile

Ocugen (OCGN) is a biopharmaceutical company focusing on discovering, developing, and commercialising gene therapies to cure blindness illnesses and creating a Covid-19 vaccine. 

Founded in 2006, Ocugen became a public company in 2014. The company’s shares are traded on the Nasdaq under the symbol OCGN.

Projects in the pipeline are Covid-19 vaccines, a Modifier Gene Therapy Platform and Novel Biologic Therapies for Retinal Diseases. 

For the Covid-19 vaccine, the company, in collaboration Bharat Biotech, was developing, manufacturing and commercialising COVAXIN for the prevention of the disease for US and Canada markets. COVAXIN is a whole-virion inactivated Covid-19 vaccine candidate and is formulated with the inactivated SARS-CoV-2 virus.

The Modifier Gene Therapy Platform is designed for retinal diseases, including retinitis pigmentosa (RP), leber congenital amaurosis (LCA) and dry age-related macular degeneration (AMD). The technology is licensed from the Schepens Eye Research Institute of Massachusetts Eye and Ear (Harvard Medical School).

The company is developing OCU200, a biologic product candidate for the treatment of severe vision-threatening diseases such as diabetic macular edema (DME), diabetic retinopathy (DR), and wet age-related macular degeneration (Wet-AMD). 

Patients affected by these diseases have common symptoms, such as blurry vision and increasing visual loss as the condition develops.

Another technology in the pipeline is OCU400, the company’s first product candidate developed with its Modifier Gene Therapy Platform.

Ocugen is headquartered in Malvern, Pennsylvania.

Industry: Biotechnology & Medical Research (NEC)

11 Great Valley Parkway
MALVERN
PENNSYLVANIA 19355
US

News

CPI, consumer price index symbol.

Disinflation resumes in the US as CPI drops in April

The rate of growth in US consumer prices dropped in April leading markets to price in more chances of rate cuts from the Fed

11:24, 16 May 2024

Stock market crash: how far can the S&P 500 go?

After a remarkably strong first quarter, the US stock market pulled back in April for the first time since October last year.

11:46, 10 May 2024

Bank of England preview: possible rate cut in summer?

The Bank of England (BoE) is widely expected to keep interest rates unchanged when it meets later this week. Data from Reuters shows a 90% chance of no change to the current rate of 5.25%, but the central bank will need to decide whether to change the messaging about rate cuts this year as traders will be paying close attention to any rate-cut clues.

12:39, 8 May 2024

We’re partnering with Newsquawk

Filter out the noise and focus on the news that matters.

08:32, 23 April 2024

US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft

The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.

15:56, 22 April 2024

Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported

Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.

07:56, 17 April 2024

US Earnings Season : JP Morgan, Citigroup, Wells Fargo

The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

16:03, 11 April 2024

People also watch

ETH/USD

3,080.07 Price
-1.580% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

Gold

2,415.65 Price
+1.590% 1D Chg, %
Long position overnight fee -0.0187%
Short position overnight fee 0.0105%
Overnight fee time 21:00 (UTC)
Spread 1.50

XRP/USD

0.51 Price
-2.550% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

BTC/USD

66,294.45 Price
-1.280% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

Still looking for a broker you can trust?

Join the 610,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading